Lexcura Clinical Insights

Episode two of the emergency department series is triage, and Michelle Carroll says plainly that if you listen to only one episode in the series, this is the one.

Triage is a decision made by one nurse in two to five minutes that determines how long the patient waits, when a physician sees them, and whether anyone is required to check on them in between. Undertriage is the single most common root of ED cases.

She explains the fiv...

This episode opens a five-part series on the emergency department, the place where more medical-legal cases begin than anywhere else in the hospital.

Michelle Carroll starts with the fact that shapes everything about the ED: it's the only part of the hospital that doesn't choose its patients. It sorts them. A triage nurse assigns an acuity level in the first minutes, and everything after depends on that number. The ED record refle...

The medication harm series closes with chemical restraint: a drug given not to treat a condition but to control behavior for staff convenience, prohibited by federal nursing home regulation, and the medication harm most often missed because it looks like treatment. Michelle Carroll is careful with the distinction. Antipsychotics and sedatives have legitimate uses. The question is whether this drug, for this resident, was prescribe...

Episode four of the medication harm series is the patient's home, a setting most attorneys don't think of for medication cases because the home health nurse isn't administering the drugs. Michelle Carroll explains where the liability lives instead. A patient comes home from the hospital with a new medication list while the old bottles are still in the cabinet. Some drugs were stopped, some changed, some replaced. Federal condition...

Episode three of the medication harm series is the nursing home, and Michelle Carroll opens with a picture of what a medication pass actually looks like: one nurse, a rolling cart, thirty residents, and a morning pass that is supposed to take an hour and takes three. The errors in that setting are different from hospital errors. She walks through the main categories: omissions charted as given or refused, timing errors that are sy...

Episode two of the medication harm series is the hospital, where the drugs are strong, often intravenous, and the margin between a therapeutic and a harmful dose is narrow. Michelle Carroll reframes the hospital medication case around a single question: which safety system should have caught this, and what does the record say about why it didn't. She walks through the four main systems and what each one logs. Barcode scanning reco...

This episode opens a five-part series on medication harm, taken setting by setting: the hospital, the nursing home, the patient's home, and the particular category of drugs used as restraint. Michelle Carroll starts with the five rights every nurse learns in the first week of school, right patient, drug, dose, route, and time, and reframes them as a map of where medication errors break. Right dose causes the most serious harm. Rig...

The diagnostic delay series closes with the cardiac miss: a patient who came to the emergency department with chest pain, got a workup, went home, and collapsed within days.

Michelle Carroll explains why these charts look reasonable at first read and what the record usually shows underneath. A single troponin, drawn before heart muscle damage had time to register, treated as a clean negative. An EKG that w...

Episode four of the diagnostic delay series is cancer, where the record is spread across a primary care office, an imaging center, a specialist, a pathology lab, and a hospital, and the delay usually lives in the gap between two of them.

Michelle Carroll opens with the single largest category of cancer delay: the incidental finding. A CT ordered for kidney stones or a car accident, a radiologist who notes ...

Episode three of the diagnostic delay series is sepsis, the condition Michelle Carroll calls the clearest example in medicine of a diagnosis that is visible in the chart before the clinicians see it.

She explains in plain terms what sepsis is, why the treatment is simple but the timing is everything, and how hospitals are measured on a three-hour bundle that starts at “time zero,” the moment se...

Episode two of the diagnostic delay series takes on stroke, the clearest example in medicine of a condition where the clock is the treatment.

Michelle Carroll starts with last known well, the single most important time in a stroke chart and one that is frequently never documented. She explains how the treatment window is built around it, why triage notes like “found with slurred speech” don&rsq...

This episode opens a five-part series on diagnostic delay and missed diagnosis, the single most common pattern in the cases Lexcura Summit reviews.

Michelle Carroll explains the difference between a missed diagnosis and a delayed one, and why delay cases are so easy to misjudge at intake: the chart says stroke, or sepsis, and everything after that line reads like competent medicine. The problem lives in th...

When a family chooses hospice, they’re giving up curative treatment in exchange for one promise: comfort. In part four of our end-of-life series, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, looks at what happens when that promise breaks down.

Hospice is under more federal scrutiny than ever. CMS has put a nationwide freeze on new hospice enrollments, suspended payments ...

A patient can do everything right. She signs a living will, completes a POLST form with her doctor and chooses no CPR. Then a hospital stay, a missing transfer packet and a default order change her record to “full code.” When she’s found unresponsive, the nurse follows what the record says.

In this second episode of the end-of-life series on Lexcura Clinical Insights, Michelle Carroll, Fo...

A patient can do everything right. She signs a living will, completes a POLST form with her doctor and chooses no CPR. Then a hospital stay, a missing transfer packet and a default order change her record to “full code.” When she’s found unresponsive, the nurse follows what the record says.

In this second episode of the end-of-life series on Lexcura Clinical Insights, Michelle Carroll, Fo...

This year brought the biggest expansion of medical aid in dying since Oregon passed the first law in the 1990s. Delaware’s law took effect in January, New York’s in August, and Illinois’s in September. That brings the total to fourteen U.S. jurisdictions.

In this episode of Lexcura Clinical Insights, Michelle Carroll, Founder and Chief Clinical Strategist of Lexcura Summit, walks through ...

On September 8, 2026, HHS announced $383.4 million in grants through SAMHSA to strengthen behavioral health treatment, prevention, and crisis response. About $252 million goes to the 988 Suicide and Crisis Lifeline, suicide prevention, and mobile crisis services. The rest goes to substance use treatment and prevention, child traumatic stress programs, rural EMS training, and programs that bring primary care and behavio...

In September 2026, CMS placed eleven durable medical equipment suppliers on its Preclusion List, cutting off their Medicare Advantage and Part D payments. The suppliers were tied to more than $3.4 billion in suspected fraudulent billing in 2025 and 2026. Every one of them billed for patients who had already died. Many had no claims history before 2025, and four had already been removed from traditional Medicare before ...

In January 2026, the CDC approved a revised childhood immunization schedule without the usual vote by its expert advisory committee. Recommendations for hepatitis A, meningococcal ACWY, RSV, rotavirus, and influenza moved away from routine vaccination for all children, and the HPV series was reduced to a single dose. The American Academy of Pediatrics and other groups sued. In March 2026, a federal court in Massachuset...